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Abstract:  Background: Studying 
the acute postnatal changes of new-
born thyroid function is essential 
for determining the best timing of 
screening for congenital hypothy-
roidism. There is paucity of litera-
ture on neonatal thyroid function 
and particularly the postnatal 
changes in Nigeria.  
Objectives: To describe the profile 
of thyroid function in cord blood 
and the postnatal changes at 
24hours and 72hours in healthy 
term neonates delivered in Usmanu 
Danfodiyo University Teaching 
Hospital (UDUTH), Sokoto. 
Subjects and methods: This was a 
prospective, descriptive and cross 
sectional study conducted over a 
six month period (between July-
December 2009). Forty seven con-
secutively delivered healthy term 
neonates had their serum T3, T4, 
TSH assayed at birth, 24 and 
72hours using the Enzyme linked 
immunosorbent assay (ELISA) 
technique. Data obtained are pre-
sented as mean, median and stan-
dard deviation (SD). Paired- t- test 
was used for statistical inference. 
Results: The mean (SD) of the se-
rum hormone concentrations in 
cord blood, and venous blood at 
24hours and 72hours, respectively 
were as follows: T3, 0.58 (0.56)
nmol/l, 1.15 (0.77)nmol/l, 0.83 
(0.74)nmol/l; T4, 91 (83.1)nmol/l, 
121.5 (106.4)nmol/l, 104.2 (84.2) 
nmol/l; and TSH, 5.95 (5.81)mU/l, 
8.61 (8.34)mU/l, 2.52 (2.61) mU/
l.. The mean serum T3, T4 and TSH 
at 24hours were higher than cord 
blood levels (p<0.001, 0.03, 0.05 
respectively). The mean serum T3
and T4 at 72hours, were higher 
than cord blood levels (p = 0.07, 
0.44), whereas TSH at 72hours 
was significantly lower than cord 
blood levels; (p<0.001). 
Conclusions: There was a rise, 
above cord level, of T3, T4 and 
TSH at 24hours, and a decline at 
72hours, the latter being most 
marked in TSH. It is recommended 
that serum TSH taken at or greater 
than 72hours of life may be util-
ized for screening for congenital 
hypothyroidism in term babies, 
using postnatal age appropriate 
reference ranges. Serum T3, T4 
should then be assayed for confir-
mation in all neonates with a posi-
tive TSH screening. 
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Thyroid hormones in normal quantities are vital for 
physical growth and mental development during fetal 
and postnatal life1. In the developing human fetus,  
thyroid hormone deficiency is associated with sever 
retardation of growth and maturation of almost all organ 
systems2. However, the sensitivity of different organs to 
thyroid hormone deficiency varies. The brain is particu-
larly susceptible to damage during the fetal and early 
postnatal period3. It has been established that nerve cells 
require thyroid hormone for their development. Thyroid 
hormone is therefore, essential for normal brain  
development2-4. 
 
Most infants with congenital hypothyroidism are asymp-
tomatic at birth5. This may probably be because of an 
ectopic thyroid gland with clinically significant thyroid 
function, partial defect in thyroid hormone synthesis, or 
to the moderate amount of maternal T4 that crosses the 
placenta and is able to boost fetal levels within 25-50% 
of normal levels at birth5. The clinical picture is fully 
developed by 3 – 6 months of age5, by which time ther-
apy may not prove 100% useful in restoring neurodevel-
opment to normal6. Prognosis for neurodevelopment is 
excellent if therapy is instituted at the postnatal age of 
one month or less.7,8 Less than 5% of neonates with con-
genital hypothyroidism are diagnosed clinically first, 
before laboratory confirmation.5 The clinician is, there-
fore, dependent on neonatal screening tests for the early 
diagnosis.7 Routine screening is, however, not yet uni-
versal in some countries such as Nigeria, and may be 
responsible for the lower prevalence and/or poor docu-
mentation of congenital hypothyroidism in the literature.  
 
The American Academy of Paediatrics advocates that 
blood specimen for screening should be collected opti-
mally by 2-4 days of age7,  but there are situations in 
which this is virtually impossible. In infants discharged 
before 48 hours of life following delivery, blood should 
be obtained before discharge7. In most screening pro-
grams blood is collected for screening between 5-6 days 
of age9. Some researchers have documented the use of 
cord blood TSH in term neonates as a screening tool for 
congenital hypothyroidism9,10.  They argue that serum 
TSH at birth does give reliable and good result. To but-
tress their argument, they opined that the acute changes 
take a few hours post-delivery to develop hence it does 
not affect cord levels of TSH. Furthermore, the leve  of 
TSH in the cord reflects the concentration of this or-
mone in the fetus and not early neonatal period that is 
fraught with acute changes in TSH levels. Lastly, quan-
tity of TSH in the cord is not affected by maternal levels 
as compared to T4 levels because TSH does not cross the 
placenta because of its high molecular weight 9,10,11. 
 
Thyroid profiles have been described in neonates in 
North America and Europe12,13 with the establishment of 
reference values which are utilized by neonatal screen-
ing centers12,13. However, in Africa, limited studies have 
been documented14,15. It was, therefore, considered that 
since no study has been done describing thyroid profile 
in term neonates in Sokoto, and little is known about its 
postnatal changes in Nigerian neonates, particularly in 
this part of the country, it was pertinent to undertake this 
study. Moreover, studying the thyroid profile of Nige-
rian neonates is a pre-requisite for the establishment of 
neonatal screening centers for congenital hypothyroid-




Subjects and Methods 
Study location 
 
This study was carried out in the Labour Ward and Spe-
cial Care Baby Unit (SCBU) of UDUTH, Sokoto, 
Sokoto State, Nigeria. The SCBU of the hospital adjoins 
the Labour ward and admits all babies that are highrisk; 
this is inclusive of babies with abnormal birth weight, 
those who experienced perinatal complications, post 
caesarean section and other instrumental deliveries and 
sick newborns (the latter are kept in a demarcated sec-
tion of the SCBU).  
 
UDUTH is sited at No. 1 Nadama Road within the 
Sokoto Metropolis, the Seat of the Caliphate and the 
State capital. It has a 554 bed capacity and an annual 
delivery rate of approximately 2,500 babies. It also 
serves two neighboring states (Zamfara and Kebbi) and 
a contiguous neighboring country, Niger Republic. 
Sokoto State is located in the Northwestern geopolitical 
zone of Nigeria with a population of 3.69million people 
and annual growth rate of 3%16. It is situated at 900m 
above sea level16.  It lies between latitude 100and 140N, 
and longitude 3031 N and 7071E of the equator17. The 
climate is semi-arid with a hot dry season that span  
from October to April, a rainy season which starts in 
May and lasts till September17, the cold harmattan 
months spanning from December to February. Annual 
rainfall ranges between 550mm and 600mm17. The tem-
perature fluctuates within wide limits from about 150C 
during the cold night to over 400C during the hot days17. 
The low ambient temperature during the cold season 
could predispose to higher TSH surge18. Most of the 
ethnic groups are represented, but the majorities ar  the 
indigenous Hausas/Fulani population. The society is 
basically agrarian with majority living in the rural reas. 
Ethical permission to carry out this study was obtained 
from the UDUTH Ethics Committee. Informed verbal 
and written consent was obtained from the parents of the 




This was a prospective, descriptive and cross sectional 
study conducted over a six (6) month period between1st 
July 2009 - 31st December 2009.  
Inclusion criteria: These were healthy term neonates, 
delivered in UDUTH, Sokoto and informed written pa-
rental consent.  
Exclusion criteria: They include maternal history/
family history of thyroid disease or ante-partum inges-
tion of anti-thyroid drugs19,20.  Maternal goiter, sick new-
borns (because of the effect of illness on thyroid func-
tion)21, 22,  probable sepsis21,  severe respiratory distress 
or cardiopulmonary illness22, perinatal asphyxia/
seizures23,  history of blood transfusion in the neonates.7 
Recruitment Procedure: The parturient mothers and 
some expectant fathers were addressed during labour for 
informed/written consent. Forty seven (47) consecutive 
babies delivered between 5am and 1pm, who met the 
inclusion criteria, were recruited for the study. This spe-
cific delivery time preference was chosen to allow for 
uniformity in the time of blood sample collection at
24hours and 72hours, as well as to remove any circadian 
bias ( i.e. Circadian rhythm of TSH secretion character-
ized by low concentrations during the daytime, increase 
in the evening and peak shortly before sleep)24.  
 
A thorough physical examination (general and systemic) 
was carried out on each neonate after birth and on subse-
quent follow up visits, to ensure they were healthy.  
Apgar scores, birth weights, gestational age by dates or 
ultrasound, gender, maternal complication (medical or 
obstetric), parity and others were documented in the pro-
forma data sheet. The importance and implication of 
outcome of the study was further explained to the moth-
ers after delivery. The mothers were also examined for 
goiter by palpation of their anterior neck while asking 
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them to swallow, the investigator standing behind the
mothers during palpation. History of ingestion of anti-
thyroid medication or family history of thyroid disease 
was taken and documented in the pro-forma data sheet. 
Follow up written appointments were subsequently 
given to the mothers to bring their babies at 24hours, 
and 72hours. Blood samples were obtained from en-
rolled neonates for the assay of T3, 4 and TSH. Mothers 
were reassured and given incentives for transportati n 
during follow up visits.   
Blood Sampling: Two milliliters (2mls) of umbilical 
venous and arterial mixed blood was obtained by gently 
milking a 15-20cm length of the fetal side of the severed 
umbilical cord within five minutes of birth of each 
baby.9 Two milliliters (2mls) of venous blood was also 
obtained by venipuncture of a peripheral vein at 
24hours, and 72hours using a 21G needle without sy-
ringe, after cleaning the site with a cotton wool wet ith 
methylated spirit. The blood samples were collected into 
a plain sample bottle without anticoagulant and allowed 
to clot. It was subsequently spun in a centrifuge at 4000 
revolution per minute for five minutes. The serum was 
decanted into small tubes using a pipette and kept frozen 
at -200C in the freezer of the Chemical Pathology De-
partment of UDUTH until required for analysis.  
Blood Analysis Technique: A solid phase enzyme im-
munoassay utilizing the competitive binding principle 
(ELISA) was used for the assay of Triiodothyronine, 
thyroxine, and thyroid stimulating hormone25. The val-
ues of T3, T4 and TSH were expressed in, ng/dl, µg/dl 
and µIU/ml, respectively. To facilitate comparison with 
other studies, these units were converted to their corre-
sponding SI units as follows: T4 µg/dl×12.87=nmol/l, T3 
ng/dl×0.01503= nmol/l and TSH µIU/ml= mU/L.26 
The commercial test kits were obtained from Syntron 
Bioresearch, Inc California, USA. The test procedur for 
triiodothyronine (T3), thyroxine (T4) and thyroid stimu-
lating hormone (TSH) were as contained in the Syntron 
Bioresearch, Inc. Micro well T3 EIA catalogue 3810-96, 
T4 EIA ref #2210-96 and TSH EIA ref #2211-96, re-
spectively.       
Data Analysis: The data from pro-forma sheets and 
results of serum T3, T4 and TSH were entered into a mi-
crocomputer (Microsoft excel 2003). A double check 
entry approach was utilized to ensure accuracy of data 
entered. Measures of statistical location like mean, stan-
dard deviation, median and range were generated using 
the Statistical Package for Social Sciences (SPSS) ver-
sion 20. Statistical comparison involved the paired- t-
test. Probability (p) value less than or equal to 0.05 were 





General characteristics of the study population 
 
Forty seven apparently healthy term neonates were en-
rolled for the study. Eighteen (38%) were males and 
twenty nine (62%) were females. (M: F =1:1.61).  All
subjects had Apgar scores between 8 and 10 at 1 and 5 
minutes, respectively. 
Birth weights and gestational ages of the studied  
Neonates 
 
The birth weights of the neonates ranged from 2,150g to 
4,900g {mean (SD) 3,230g (2.141)g}. There were thirty 
eight (81%), Appropriate for Gestational Age (AGA), 
three (6%), Small Gestational Age (SGA), and six 
(13%), Large for Gestational Age (LGA) neonates. Ges-
tational ages ranged from 37 to 42 weeks [Mean (SD) 39 
(20) weeks] 
 
Mode of delivery 
 
 Thirty (64%) of the neonates were delivered via caesar-
ean section (CS), sixteen (34%) by spontaneous vertex 
delivery (SVD) and one (2%) by vacuum extraction. 
Age, parity and antenatal clinic attendance of mothers: 
Forty four (93%) of the mothers were booked and three 
(7%) were un-booked. Thirty eight (80%) of the mothers 
were multiparous and nine (20%) were primiparous. 
Maternal ages ranged from 16 to 39 years. (Mean (SD) 
age 26 (14) years). 
 
Serum concentrations of T3, T4, and TSH: The mean and  
median serum concentration of serum T3, 4, and TSH 
in cord blood, at 24hours and 72hours are as shown in 
Table 1.Comparison  between  two means was done 
using the paired- t- test. There was a rise above cord
blood levels in all the hormones at 24hours (p = < 0.001, 
0.03, 0.05 respectively) and a fall at 72hours (p= 0.05, 
0.29, 0.001 respectively), the fall being most marked in 
TSH. At 24 hours, the mean T3 was about twice the cord 
blood value: the mean T4 level increased by about 30% 
of the cord levels while that of TSH increased by aout 
one and a half times of the cord levels. 
At 72 hours, the mean T3, T4 and TSH all fell below the 
24-hour levels. However, while the values of T3 and T4 
remained above the cord levels that of TSH fell to ab ut 
half the cord value. 
 
Table 1: The mean, standard deviation and the median of se-
rum T3, T4, and TSH in cord blood of term neonates, and ve-
nous blood at 24hours and 72hours. 
                              4.66                    7.08                  1.71 
 CB: Cord blood vs Versus 
T3:     
a vs b    p=<0.001;   a vs c    p=0.05   
T4:    
d vs e     p=0.03;       d vs f    p=0.29 
TSH: g vs h     p=0.05;       g vs i   p=0.001      
 
Thyroid profile of term AGA neonates in Cord blood 
and venous blood at 72hours as seen in this study com-
pared with a similar study in Benin are shown in  
Table 2. Similar pattern of a higher mean serum T3 and 
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T4 and lower TSH at 72hours compared to cord blood 
levels was demonstrated. 
The neonates in Benin had a lower mean serum T4 and a 
higher mean serum T3 and TSH than was demonstrated 
in this study both in cord blood and at 72hours.  
 
.Table 2: Neonatal thyroid profile of term Appropriate for Gesta-
tional Age (AGA) neonates in Cord blood and venous blood at 






The present study has demonstrated higher mean levels 
of serum T3 and T4 at 24 hours in term neonates com-
pared to cord blood levels of these hormones(<0.001, 
0.03). This is consistent with the findings of Jacobsen et 
al27 in Copenhagen, Denmark.   
The reason for the higher levels of serum T3 and T4 at 24 
hours is most likely due to adaptive changes in the new-
born, characterized by early rapid increase in serum 
TSH in the first few hours of life post-delivery, in all 
groups of newborn18. This surge of TSH is called the 
physiologic surge, and is as a result of extra-uterine 
cooling18. The TSH surge stimulates the thyroid gland to 
increase production of thyroid hormones (T3 and T4)
18, 28 
in order to adapt to extra uterine life via synergistic  
action with catecholamine to increase non shivering 
thermogenesis. The finding of higher relative increases 
of serum T3 above cord levels, at 24 hours, compared to 
T4, confirms earlier reports that the increased thyroid 
hormone secretion following the TSH surge is due more 
to T3 than T4
27,29. 
 
The finding of low T3 at birth confirms the earlier re-
ports that the fetus is T3 deficient most likely due to the 
reduced capacity to de-iodinate T4 to T3 in the extra thy-
roidal tissues.29 The rapid increase in serum T3 after 
delivery at a time when the capacity to convert T4 to T3 
is reduced suggests that the increment in serum T3 is due 
predominantly to increased T3 secretion from the thyroid 
gland stimulated by the TSH surge rather than increased 
conversion of T4 to T3 in the peripheral tissues.
29 
The subsequent decline in T3 to levels above cord blood 
at 72hours, is consistent with earlier reports27,29, and is 
due to the waning of the physiologic TSH surge usually 
at 48-72 hours18. The declining levels of T3 coinciding 
with falling TSH seems to agree with this explanation. 
The decline in serum T4 at 72 hours is consistent with 
earlier report by Jacobsen et al27,7 The fact that mean 
TSH at 72 hours fell to about half the cord level is a 
reflection of the fact that necessary homeostatic tem-
perature adjustments are complete and the stimulus for 
physiologic surge of TSH, removed. Therefore, newborn 
                     Sokoto (Present Study)                       Benin Study 
                        Mean (Range)                              Mean (Range) 
Hormones           n=38                                              n=114 
                        Birth                 72hrs               Birth                 72hrs 
 
 T3nmol/L   0.62 (0.01-2.78)    0.83(0.01-3.69)   0.89(0.65-1.52)  1.06(0.71-1.61) 
 T4nmol/L   91.3 (0.4-265.9)    104(1.0-274.6)    75.48(47-120)  101.38(62.2-130.5) 
TSH mU/L 5.89 (0.45-35.76)  2.52(0.04-11.97) 13.59(6.2-26.1)  10.25(5.0-22.1) 
screening at 72 hours will likely give reliable result  
applicable to the neonate in stable state. 
 
A similar study in Benin15 was conducted in the year 
2005 on term AGA neonates. Their serum T3, T4 and 
TSH were assayed in cord blood and at 
72hours.Comparison with this study, therefore, was only
possible with the term AGA group which were thirty 
eight in number. Coincidentally a similar method of 
assay was used (ELISA technique), though the test kits 
were different. The Benin study15 showed lower mean 
serum T4 and higher mean serum T3 and TSH than this 
present study. This observation may be due to the differ-
ences in location, Sokoto being a mild goiter zone while 
Benin is in an area of moderate goiter. 
Previous work done has shown that newborns from ar-
eas of iodine deficiency as seen in the goiter belts have a 
higher frequency of elevated TSH levels and low T4 
values than is found in areas where iodine intake is nor-
mal even though the mothers may be clinically and bio-
chemically euthyroid30. It may be reasonable to proffer 
that this would occur more profoundly in areas with 
moderate to severe iodine deficiency than the mildly 
deficient areas. One of the possible explanations given is 
that in the presence of iodine deficiency, the newborn 
thyroid is unable to obtain an adequate iodine supply 
because of the competition by the mother’s thyroid, also 
eager for iodine. This may result in more severe reduc-
tion in the iodine content in the newborn thyroid and 
consequently reduction in its functional capacities. The 
demonstrated  pattern of postnatal changes at 72hours in 
this study (higher mean T3, T4 and lower TSH) com-
pared with mean cord blood levels is similar to that re-
ported in Benin15. This suggest that the postnatal 
changes in neonatal thyroid function are qualitatively the 
same irrespective of geographical location but there may 
be slight quantitative differences. 
 
 In the same study done in Benin,15 the researchers 
found no significant differences between the mean cord 
blood T3, T4, and TSH and the mean serum values of 
these hormones at 72hours (p=0.36, 0.08, 0.33 respec-
tively), meaning that it makes no difference whether 
screening for congenital hypothyroidism is done with 
cord blood or venous blood at 72hours, consequently the 
same reference values may be utilized. This is however, 
contrary to this present study which demonstrated differ-
ences between the cord blood and 72hours mean con-
centrations of T3 and TSH (p=0.05, 0.001 respectively). 
The mean T4 however was not significantly different 
from the cord blood levels (p=0.29). The reasons for the 
differences in findings of the two studies     ( present 
study and Benin study) is not quite clear, but may be 
related to the smaller number of AGA neonates (38) 
recruited in this study, compared to the larger number in 
the Benin study (114), the varying modes of delivery in 
this study (CS, SVD, vacuum). All the subjects enrolled 
in the Benin study were delivered by SVD. Conflicting 
reports have earlier been documented by various  






mean T3 levels peaked at 24 hours and decreased at 72 
hours in term healthy neonates, while T4 levels increased 
slightly but progressively from birth to 24hours and de-
clined at 72 hours. However, the mean TSH levels 
peaked at 24 hours before declining at 72 hours to lower 
than cord blood levels. It is therefore recommended that 
serum TSH assayed at or greater than 72hours may be 
utilized for screening for congenital hypothyroidism, 
particularly where cord TSH is missed (e.g. home deliv-
eries), and the results should be interpreted using post 
natal age appropriate reference ranges. Serum T3, T4   
and repeat TSH should then be assayed for confirmation 
in all neonates with a positive TSH screening. There 
should be vigorous pursuit of further multicenter col-
laborative evaluations of neonatal thyroid function in 
Nigeria. 
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